Guangxi Dahai Sunshine Pharmaceutical

Guangxi Dahai Sunshine Pharmaceutical is a modern pharmaceutical company based in Nanning, China, specializing in the research, development, manufacturing, and marketing of traditional Chinese patent medicines, chemical drugs, and active pharmaceutical ingredients (APIs). Formed through the integration of Beihai Sunshine Pharmaceutical and Guangxi Heli Pharmaceutical, the company operates seven GMP-compliant production lines covering tablets, granules, capsules, powders, ointments, and APIs. Its core product portfolio includes Hanfangji A Tablet (tetrandrine) for pneumoconiosis and oncology, Weibikang (pearl layer powder) for gastric ulcers, and Yimaikang Capsules for cardiovascular diseases. The company actively collaborates with academic institutions like Guangxi University of Chinese Medicine to develop ethnic and specialty medicines.